Phathom Pharmaceuticals
PHAT
PHAT
84 hedge funds and large institutions have $919M invested in Phathom Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.19% less ownership
Funds ownership: 78.58% → 78.4% (-0.19%)
4% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 23
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Holders
84
Holding in Top 10
6
Calls
–
Puts
$3K
Top Buyers
| 1 | +$30.7M | |
| 2 | +$7.49M | |
| 3 | +$7.29M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.06M |
| 5 |
Two Sigma Investments
New York
|
+$2.05M |
Top Sellers
| 1 | -$26.7M | |
| 2 | -$8.22M | |
| 3 | -$5.07M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$5.01M |
| 5 |
LM
Luminus Management
Houston,
Texas
|
-$4.22M |